Begin main content

Call for Patient Input and Clinical Experts: halobetasol propionate and tazarotene

Published on: January 7, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s). 

Brand name TBC
Generic name halobetasol propionate and tazarotene
Manufacturer Bausch Health, Canada Inc.
Indication(s) Psoriasis, moderate to severe plaque
Project Number SR0600-000
Call for patient input 2019-01-07
Patient input deadline 2019-02-26
Submit patient input Submit
Register as Clinical Expert Register